Pharmacokinetics of oral and intravenous rifampicin during chronic administration
Tóm tắt
Từ khóa
Tài liệu tham khảo
Acocella G, Bonollo L, Garimoldi M, Mainardi M, Tenconi LT, Nicolis FB (1972) Kinetics of rifampicin and isoniazid administered alone and in combination to normal subjects and patients with liver disease. Gut 13:47–53
Acocella G, Bonollo L, Mainardi M, Margaroli P, Tenconi LT (1977) Serum and urine concentrations of rifampicin administered by intravenous infusion in man. Arzneimittelforsch 27:1221–1226
Acocella G, Mattiussi R, Segre G (1978) Multicompartmental analysis of serum, urine and bile concentrations of rifampicin and desacetyl-rifampicin in subjects treated for one week. Pharmacol Res Commun 10:271–288
Binda G, Domenichini E, Gottardi A, Orlandi B, Ortelli E, Pacini B, Fowst G (1971) Rifampicin, a general review. Arzneimittelforsch 21:1907–1977
Boman G (1974) Serum concentration and half-life of rifampicin after simultaneous oral administration of aminosalicylic acid or isoniazid. Europ J Clin Pharmacol 7:217–225
Breimer DD, Zilly W, Richter E (1977) Influence of rifampicin on drug metabolism: differences between hexobarbital and antipyrine. Clin Pharmacol Ther 21:470–481
Furesz S, Scotti R, Pallanza R, Mapelli E (1967) Rifampicin: a new rifamycin. Arzneimittelforsch 17:534–537
Holdiness MR (1984) Clinical pharmacokinetics of the antituberculosis drugs. Clin Pharmacokin 9:511–544
Houin G, Beucler A, Richelet S, Brioude R, Lafaix C, Tillement JP (1983) Pharmacokinetics of rifampicin and desacetylrifampicin in tuberculous patients after different rates of infusion. Ther Drug Monit 5:67–72
Keberle H, Krüger-Thiemer E, Sackmann W, Schmid K, Seydel J (1967) Pharmakokinetische Untersuchungen an Rifampicin. In: Spitzy KH, Haschek H (eds) Proc 5th Int Congr Chemotherapy, Wien. Vol 4, pp 157–160
Keberle H, Schmid K, Meyer-Brunot HG (1968) The metabolic fate of Rimactane in the animal and in man. In: Dettli L (ed) A symposium on RimactaneR. Ciba, Basel, pp 20–27
Kenny MT, Strates B (1981) Metabolism and pharmacokinetics of the antibiotic rifampin. Drug Metab Rev 12:159–218
Kohno H, Hata B, Tsuchiya T, Kubo H (1984) Enzyme induction by rifampicin and its time-dependent pharmacokinetics. Yakugaka Zasski (=J Pharmacol Soc Japan) 14:884–888
Lecaillon JB, Febvre N, Metayer JP, Souppart C (1978) Quantitative assay of rifampicin and three of its metabolites in human plasma, urine and saliva by high-performance liquid chromatography. J Chromatogr 145:319–324
Loos U, Musch E, Mackes KG, Reetz KP, Gläser R, v. Sassen W, Labedzki L, Schwabe HK, Hengstmann J, Eichelbaum M (1983) Vergleich oraler und intravenöser Rifampicin-Gabe bei der Behandlung offener Lungentuberkulosen. Prax Klin Pneumol 37:482–484
Mouton RP, Mattie H, Swart K, Kreukniet J, de Wael J (1979) Blood levels of rifampicin, desacetylrifampicin and isoniazid during combined therapy. J Antimicrob Chemotherapy 5:447–454
Musch E, Loos U, Mackes KG, Reetz KP, Gläser R, v. Sassen W, Labedzki L, Schwabe HK, Hengstmann J, Eichelbaum M (1982) Klinische Verlaufsstudie bei intravenöser Rifampicinapplikation in the Tuberkulosetherapie. Verh Dtsch Ges Inn Med 88:638–644
Nakagawa H, Sunahara S (1975) Glucuronidation and desacetylation in the metabolism of rifampicin in man. 23 rd Int Tuberculosis Conf, Mexico City. Cited by Acocella (4)
Nakagawa, H, Umene Z, Sunahara S (1979) Increased desacetyl-rifampicin and adverse reactions. Bull Int Union Against Tuberculosis 54:171–172
Nitti V, Virgilio R, Patricolo MR, Iuliano A (1977) Pharmacokinetic study of intravenous rifampicin. Chemotherapy 23:1–6
Riess W (1968) The optimum dosage schedule for Rimactane. In: Dettli L (ed) A symposium on RimactaneR. Ciba, Basel, pp 36–42
Remmer H, Schoene B, Fleischmann RA (1973) Induction of the unspecific microsomal hydroxylase in the human liver. Drug Metab Disp 1:224–230